WILLIAM B. KANNEL, M.D.; WILLIAM P. CASTELLI, M.D.; TAVIA GORDON; PATRICIA M. MCNAMARA
▸Requests for reprints should be addressed to William B. Kannel, M.D., National Heart Institute, 25 Evergreen St., Framingham, Mass. 01701
KANNEL W., CASTELLI W., GORDON T., MCNAMARA P.; Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study. Ann Intern Med. 1971;74:1-12. doi: 10.7326/0003-4819-74-1-1
Download citation file:
Published: Ann Intern Med. 1971;74(1):1-12.
Risk of coronary heart disease over 14 years was examined prospectively in 2,282 men and 2,845 women according to their antecedent cholesterol and lipoprotein status. An increased risk proportional to antecedent serum cholesterol was found whether or not it was associated with elevated Sf20-400 prebeta lipoprotein. When adjustment was made for the concomitant prebeta lipoprotein concentration and other factors related both to coronary heart disease risk and to blood lipids, a residual gradient of coronary heart disease risk proportional to the serum cholesterol was still evident. On the other hand, when risk of coronary heart disease was examined according to prebeta lipoprotein concentration, adjusting for cholesterol, no residual risk gradient remained in men. In women over 50, however, prebeta lipoprotein was superior to cholesterol in discriminating potential coronary heart disease cases. Risk of coronary heart disease in men can be estimated using any of the lipids evaluated: however, none proved more useful than an accurate total serum cholesterol.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Dyslipidemia, Coronary Risk Factors, Coronary Heart Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only